Our vision is to establish Santaris Pharma a/s as a leader in the field of RNA-medicines by demonstrating that the Company's proprietary Locked Nucleic Acid (LNA) Drug Platform, combined with its efficient and powerful Drug Discovery Engine, can be used to develop effective and safe therapeutics across multiple RNA-targeting approaches.